Gliadorphin
Gliadorphin[edit]

Gliadorphin, also known as gluteomorphin, is an opioid peptide that is derived from the incomplete digestion of the gluten protein. It is a type of exorphin, which are peptides that mimic the effects of endorphins and can interact with the opioid receptors in the brain.
Biochemistry[edit]
Gliadorphin is formed during the digestion of gluten, a protein found in wheat, barley, and rye. When gluten is not fully broken down in the gastrointestinal tract, peptides such as gliadorphin can be produced. These peptides can cross the intestinal barrier and enter the bloodstream, potentially affecting the central nervous system.
Mechanism of Action[edit]
Gliadorphin acts by binding to the opioid receptors in the brain, particularly the mu-opioid receptor. This interaction can produce effects similar to those of opioid drugs, such as morphine, although the potency and effects of gliadorphin are much weaker. The binding of gliadorphin to opioid receptors can influence neurotransmitter release and affect neurological and behavioral functions.
Clinical Significance[edit]
There is ongoing research into the potential role of gliadorphin in certain neurological disorders, such as autism spectrum disorder (ASD) and schizophrenia. Some studies suggest that individuals with these conditions may have altered gastrointestinal permeability, leading to increased levels of gliadorphin in the bloodstream. However, the clinical significance and implications of these findings are still under investigation.
Related Peptides[edit]
Gliadorphin is similar to other opioid peptides derived from dietary proteins, such as casomorphin, which is derived from casein in milk. Both gliadorphin and casomorphin are considered to be bioactive peptides that can influence human health and behavior.
See Also[edit]
Related Pages[edit]
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Get started with evidence based, physician-supervised
affordable GLP-1 weight loss injections
Now available in New York City and Philadelphia:
- Semaglutide starting from $59.99/week and up
- Tirzepatide starting from $69.99/week and up (dose dependent)
✔ Evidence-based medical weight loss ✔ Insurance-friendly visits available ✔ Same-week appointments, evenings & weekends
Learn more:
Start your transformation today with W8MD weight loss centers.
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian